Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 1998, p. 2122-2124, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Topoisomerase Mutations in Trovafloxacin-Resistant
Staphylococcus aureus
Joseph E.
Fitzgibbon,1,2
Joseph F.
John,1,2
Jennifer L.
Delucia,2 and
Donald T.
Dubin1,*
Department of Molecular Genetics and
Microbiology1 and
Division of Allergy,
Immunology and Infectious Diseases, Department of
Medicine,2 University of Medicine and Dentistry
of New Jersey-Robert Wood Johnson Medical School, Piscataway, New
Jersey 08854-5635
Received 28 January 1998/Returned for modification 22 April
1998/Accepted 1 June 1998
A total of 201 Staphylococcus aureus isolates were
surveyed for susceptibility to ciprofloxacin and trovafloxacin. Of 66 methicillin-resistant isolates, 89% were ciprofloxacin resistant and
6% were also trovafloxacin resistant. Trovafloxacin-resistant
strains had unusual patterns of quinoline resistance mutations in
DNA topoisomerase genes, including two mutations in the A
subunit (encoded by grlA) of topoisomerase IV.
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854-5635. Phone: (732) 235-4643. Fax: (732) 235-5223. E-mail: dubin{at}umdnj.edu.
Antimicrobial Agents and Chemotherapy, August 1998, p. 2122-2124, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Guirao, G. Y., Martinez Toldos, M. C., Peris, B. M., Alonso Manzanares, M. A., Gutierrez Zufiaurre, M. N., Martinez Andres, J. A., Munoz Bellido, J. L., Garcia-Rodriguez, J. A., Hernandez, M. S.
(2001). Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones. J Antimicrob Chemother
47: 157-161
[Abstract]
[Full Text]
-
Bébéar, C. M., Grau, O., Charron, A., Renaudin, H., Gruson, D., Bébéar, C.
(2000). Cloning and Nucleotide Sequence of the DNA Gyrase (gyrA) Gene from Mycoplasma hominis and Characterization of Quinolone-Resistant Mutants Selected In Vitro with Trovafloxacin. Antimicrob. Agents Chemother.
44: 2719-2727
[Abstract]
[Full Text]
-
Fournier, B., Zhao, X., Lu, T., Drlica, K., Hooper, D. C.
(2000). Selective Targeting of Topoisomerase IV and DNA Gyrase in Staphylococcus aureus: Different Patterns of Quinolone- Induced Inhibition of DNA Synthesis. Antimicrob. Agents Chemother.
44: 2160-2165
[Abstract]
[Full Text]
-
Anderson, V. E., Zaniewski, R. P., Kaczmarek, F. S., Gootz, T. D., Osheroff, N.
(1999). Quinolones Inhibit DNA Religation Mediated by Staphylococcus aureus Topoisomerase IV. CHANGES IN DRUG MECHANISM ACROSS EVOLUTIONARY BOUNDARIES. J. Biol. Chem.
274: 35927-35932
[Abstract]
[Full Text]
-
Gootz, T. D., Zaniewski, R. P., Haskell, S. L., Kaczmarek, F. S., Maurice, A. E.
(1999). Activities of Trovafloxacin Compared with Those of Other Fluoroquinolones against Purified Topoisomerases and gyrA and grlA Mutants of Staphylococcus aureus. Antimicrob. Agents Chemother.
43: 1845-1855
[Abstract]
[Full Text]
-
Dubin, D. T., Fitzgibbon, J. E., Nahvi, M. D., John, J. F.
(1999). Topoisomerase Sequences of Coagulase-Negative Staphylococcal Isolates Resistant to Ciprofloxacin or Trovafloxacin. Antimicrob. Agents Chemother.
43: 1631-1637
[Abstract]
[Full Text]